Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient‐centered program from Italy
Alessandra Mangia(Casa Sollievo della Sofferenza), F Campanozzi(University of Foggia), Valeria Piazzolla(Casa Sollievo della Sofferenza), Nazario Augello(University of Foggia), Giovanna Cocomazzi(Casa Sollievo della Sofferenza), Mattia Falcone(University of Foggia), Camilla Iannuzziello(Mater Health Services), Ernesto Agostinacchio(University of Bari Aldo Moro), Angelo De Giorgi(University of Foggia), Maria Franca Rina(Mater Health Services), Egidio Visaggi, Maria Maddalena Squillante(Casa Sollievo della Sofferenza), Antonio Canosa(University of Molise)
Cited by 14
Related Papers
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
The Impact of the Female Genital Microbiota on the Outcome of Assisted Reproduction Treatments
|Microorganisms|2023|46
Hepatitis C virus micro-elimination: Where do we stand?
|World Journal of Gastroenterology|2021|26
Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy
|International Journal of Molecular Sciences|2024|23